POINT Biopharma Global Inc

NASDAQ:PNT   3:59:50 PM EDT
8.58
-0.35 (-3.92%)
Earnings Announcements

Point Biopharma Reports Second Quarter 2021 Financial Results

Published: 08/13/2021 11:32 GMT
POINT Biopharma Global Inc (PNT) - Point Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update.
Q2 Loss per Share $0.15.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.19

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.20

More details on our Analysts Page.